Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose trazodone for painful diabetic neuropathy
2016-002772-27Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of trazodone in diabetic neuropathy, diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Angelini Pharma. Started Dec 2016; status: completed.
02
Drugs
trazodone
03
Conditions
diabetic neuropathydiabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-002772-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002772-27.